Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Potential Role of the Triple Receptor Agonist Retatrutide in Antipsychotic-Associated Metabolic Dysfunction Among Clozapine- and Olanzapine-Treated Schizophrenia Spectrum Disorders: A Narrative Review and Theoretical Framework

Biomedicines. 2026 Aug 31;14(9):1957. doi: 10.3390/biomedicines14091957.ABSTRACTAntipsychotic-associated metabolic dysfunction contributes substantially to cardiometabolic morbidity and premature mortality in schizophrenia spectrum disorders, with the greatest burden among...
close chatgpt icon
ChatGPT

Enter your request.

← CME/CPD